Impact of Endotest on Quality of Life in Endometriosis Patients
Official title: Impact of Endotest on Patients' Quality of Life: a Cohort Study
Run by Ziwig · NCT07560852 · Data updated 2026-11-12
This observational cohort study tests how Endotest affects quality of life for women who have a prescription for the test.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 43 Years |
| Sex | Women only |
| Enrollment | 20000 (estimated) |
| Sponsor | Ziwig Industry-sponsored |
| Locations | 7 sites (Bordeaux, Gironde and 6 other locations) |
| Status | Recruiting |
| Started | May 6, 2026 |
| Main results expected | July 31, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT07560852 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–43 with a prescription for Endotest, able to consent, and affiliated with the French healthcare system or insured abroad.
✕Probably not a fit
Participants who do not experience changes in diagnostic clarity, care pathways, or quality of life may see no measurable benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study follows women aged 18 to 43 with an Endotest prescription to explore how the test experience impacts quality of life, emotional well-being, and coping. The study uses a questionnaire-based approach to capture patient-reported outcomes related to diagnostic experience and subsequent care. It leverages sites in France under innovation funding and includes participants who are affiliated with the French healthcare system or have insurance coverage abroad. The device itself combines Next-Generation Sequencing and algorithms to identify endometriosis from saliva and is already in use in several countries. The study focuses on patient-centered outcomes rather than diagnostic performance alone.
Why it matters
Potential benefit: If successful, patients may experience improved understanding of their condition and better-guided treatment decisions based on Endotest results.
How similar studies have gone: Prior data show diagnostic performance for Endotest, but patient-centered quality-of-life impact in real-world use remains to be established and is exploratory in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with a prescription for Endotest * Women aged 18 to 43 * Who have dated and signed the consent form * Affiliated with the French healthcare system or covered by health insurance abroad Exclusion Criteria: * Contraindications for the use of Endotest: 1. Current pregnancy; 2. Medical history of cancer or HIV infection; 3. Active infection at the time of saliva collection; * Significant difficulty reading and understanding the language of the country in which the participant is located.
Where it's running
-
Clinique Tivoli Ducos
Bordeaux, Gironde, France Recruiting -
Hôpital privé Saint-Grégoire
Saint-Grégoire, Ille-et-Vilaine, France Not yet recruiting -
Groupe Hospitalier Bretagne Sud - GHBS - Lorient
Lorient, Morbihan, France Not yet recruiting -
Hôpital de Mercy - CHR Metz Thionville
Peltre, Moselle, France Not yet recruiting -
CHU de Saint Etienne
Saint-Priest-en-Jarez, Pays de la Loire Region, France Not yet recruiting -
Centre Hospitalier de Pau
Pau, Pyrénées Atlantiques, France Not yet recruiting
Show 1 more location
-
Hôpital Jacques Monod - GH du Havre
Montivilliers, Seine-maritime, France Not yet recruiting
Study contacts
- Study coordinator: Fabien Le Floc'h, Project Manager
- Email: fabien.lefloch@monitoring-force.fr
- Phone: +330630447709
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endometriosis affecting the urinary tract: long-term outcomes and kidney function
This study looks at how deep endometriosis that touches the urinary tract affects the kidneys over time in adults with hydronephrosis or ureteral blockage.
-
Ultrasound detection of superficial endometriosis on the uterosacral ligaments
The team will try to see if measuring uterosacral ligament thickness with a transvaginal ultrasound can detect superficial endometriosis in people aged 18–50 scheduled for laparoscopic gynecologic surgery.
-
Doliral food supplement for pelvic pain and quality of life in endometriosis
This trial will test whether the food supplement Doliral can reduce pelvic pain and improve quality of life for reproductive-age women with diagnosed endometriosis.
-
New adhesive drape for easier removal in wound therapy
This study tests a new type of adhesive drape for wound therapy to see if it makes removal easier and more comfortable for patients after surgery compared to the standard drape.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.